Vitamin D deficiency: Difference between revisions
| Line 56: | Line 56: | ||
==Management== | ==Management== | ||
*Supplemental vitamin D | |||
**Initial high-dosage treatment phase | |||
***1,000 IU cholecalciferol per 10 nmol/L required serum increase given daily for 2-3 months | |||
**Followed by maintenance dosage | |||
***400 IU daily for all age groups | |||
***Double dosage for premature infants, dark pigmented infants/children, children with limited sun exposure, and obese patients | |||
**Special populations may require higher dosing (i.e. parathyroid disease, chronic liver disease, renal failure, and malabsorption disorders | |||
==Disposition== | ==Disposition== | ||
Revision as of 23:59, 12 January 2017
Background
- AKA: Hypovitaminosis D
- Vitamin D
- Lipid soluble
- Acts as a hormone which:
- Stimulates intestinal calcium absorption
- Maintains adequate phosphate levels for bone development
- Regulates cell growth proliferation and apoptosis
- Modulates immune function and inflammation reduction
- Deficiency leads to impaired bone mineralization and disease such as:
- Rickets in children
- Osteomalacia and Osteoporosis in adults
Metabolism and Physiology of Vitamin D
- Vitamin D gained from diet, supplements, or sunlight exposure
- Vitamin D undergoes hydroxylation in the liver producing 25-hydroxyvitamin D
- A second hydroxylation occurs in the kidney producing 1,25-dihydroxyvitamin D which is the active form of vitamin D
- This step can occur extrarenally
- Regulated by PTH, serum calcium, and phosphorus levels
Etiology of Vitamin D Deficiency
- Inadequate intake
- Dietary sources such as fortified foods and supplements are the mainstay of vitamin D intake
- Foods rich in vitamin D include fatty fish, egg yolks, fish liver oil, and some mushrooms
- Inadequate sunlight exposure
- Synthesis of vitamin D occurs in the skin through exposure to ultraviolet B radiation from sunlight
- Factors associated with vitamin D deficiency include darker skin pigmentation, prolonged winter season, and skin coverage
- Disorders limiting vitamin D absorption
- Conditions preventing vitamin D conversion into active metabolites
Clinical Features
- Bone pain and muscle weakness
- Brittle bones
- Rickets in children
- Soft bones, skeletal deformities
- Craniotabe: abnormal softening or thinning of the skull
- Osteomalacia and Osteoporosis in adults leading to increased risk of fractures
- Rickets in children
- Associated with advancement of cancers
- Breast, colon, ovarian, and prostate
Differential Diagnosis
- Hypocalcemia
- Hyperparathyroidism
- Hypophosphatemia
- Malignancy
Evaluation
- Diagnosed by measuring the concentration of 25-hydroxyvitamin D
- This is the pre hormone, calcidiol, which is a precursor to the active form 1,25-dihydroxyvitamin D
- Insufficient vitamin D defined as a 25-hydroxyvitamin level 25-75 nmol/L (normal range 75-250 nmol/L)
- Controversy over screening adults not at risk and without symptoms
Management
- Supplemental vitamin D
- Initial high-dosage treatment phase
- 1,000 IU cholecalciferol per 10 nmol/L required serum increase given daily for 2-3 months
- Followed by maintenance dosage
- 400 IU daily for all age groups
- Double dosage for premature infants, dark pigmented infants/children, children with limited sun exposure, and obese patients
- Special populations may require higher dosing (i.e. parathyroid disease, chronic liver disease, renal failure, and malabsorption disorders
- Initial high-dosage treatment phase
Disposition
See Also
External Links
References
- 1. <Health Quality Ontario. Clinical utility of vitamin d testing: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(2): 1–93.>
